The autoimmune disease diagnosis market was estimated at USD 5.14 billion in 2022 and is likely to grow at a CAGR of 8.84% during 2023-2028 to reach USD 8.57 billion in 2028.
Market Drivers:
With increasing autoimmune diseases among the growing elderly population and mounting awareness about these diseases, development in R&D is expected to drive the global autoimmune disease diagnosis market during the forecast period.